Health Care Equipment & Services

Centene insider sale: Christopher Koster sells 47,603 shares amid CFO transition. Investors weigh routine move against strong Medicaid/Medicare fundamentals and 124% YTD upside.

Insider CFO buy at SeaStar Medical: 750 shares at $3.27 amid a steep 60% slide—signals potential upside for a low‑valued critical‑care stock.

Juvenal Tobin’s 1,730‑share sale signals rule‑based liquidity, not a loss of confidence, as Castle Biosciences surges 60% this year.

Insider buying at ACLARION spikes—CEO, CFO, and owner buy shares at $2.73, signaling confidence in its AI‑driven healthcare tech and potential upside.

Trigg Leslie’s August 17 sell‑to‑cover of 3,437 Outset Medical shares shows routine tax‑cover activity, not a bearish signal, highlighting the CEO’s long‑term ownership strategy.

Outset Medical insider John L. Brottem’s routine sell‑to‑cover of 2,632 shares shows steady confidence, not market timing.

Heartflow CEO Farquhar sells 15,560 shares at $39.06—analyzing the insider trade, its impact on the stock, and what it means for investors.

Insider buying at Xtant Medical Holdings signals confidence amid a steep year‑to‑date drop—see how execs’ moves could influence future value.

Guardant Health insider buy of 232 shares shows executive confidence amid market dips, highlighting steady support for its liquid‑tumor‑DNA platform.

Insider sale at CLARITEV: SVP Tiffani sells 8,850 shares, hinting at routine liquidity rather than a warning—watch partnership moves and market sentiment.